The performance of companies tied to flagship drugs like Viagra presents a complex investment landscape . While the initial rise of copyright, fueled by Viagra's extraordinary popularity, generated substantial profits , the loss of exclusivity in key territories has introduced considerable uncertainty . Investors are now grappling with the effect o